577 related articles for article (PubMed ID: 25040293)
1. Thulium laser (RevoLix) vaporesection versus vapoenucleation with morcellator (Piranha) for the treatment of benign prostatic obstruction: a propensity-matched multicenter analysis.
Chung JS; Kang PM; Seo WI; Oh CK; Kim SC; Park SH; Choi JH; Yoon JH; Kang DI; Chung JI
Int J Urol; 2014 Nov; 21(11):1156-61. PubMed ID: 25040293
[TBL] [Abstract][Full Text] [Related]
2. Thulium:yttrium-aluminium-garnet laser prostatectomy in men with refractory urinary retention.
Bach T; Herrmann TR; Haecker A; Michel MS; Gross A
BJU Int; 2009 Aug; 104(3):361-4. PubMed ID: 19220261
[TBL] [Abstract][Full Text] [Related]
3. 120-W 2-µm thulium:yttrium-aluminium-garnet vapoenucleation of the prostate: 12-month follow-up.
Netsch C; Pohlmann L; Herrmann TR; Gross AJ; Bach T
BJU Int; 2012 Jul; 110(1):96-101. PubMed ID: 22085294
[TBL] [Abstract][Full Text] [Related]
4. Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: results at a single institution.
Gross AJ; Netsch C; Knipper S; Hölzel J; Bach T
Eur Urol; 2013 May; 63(5):859-67. PubMed ID: 23245687
[TBL] [Abstract][Full Text] [Related]
5. Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia.
Chung JS; Seo WI; Oh CK; Kim SC; Park MC; Park SH; Yu J; Lee CH; Kim W; Park TY; Min KS; Chung JI
Investig Clin Urol; 2020 Jan; 61(1):67-74. PubMed ID: 31942465
[TBL] [Abstract][Full Text] [Related]
6. Thulium:YAG vapoenucleation in large volume prostates.
Bach T; Netsch C; Pohlmann L; Herrmann TR; Gross AJ
J Urol; 2011 Dec; 186(6):2323-7. PubMed ID: 22014812
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of 120-W thulium:yttrium-aluminum-garnet vapoenucleation of prostates compared with holmium laser enucleation of prostates for benign prostatic hyperplasia.
Hong K; Liu YQ; Lu J; Xiao CL; Huang Y; Ma LL
Chin Med J (Engl); 2015 Apr; 128(7):884-9. PubMed ID: 25836607
[TBL] [Abstract][Full Text] [Related]
8. Risk of erectile dysfunction and retrograde ejaculation associated with thulium laser vaporesection of the prostate for bladder outflow obstruction: a retrospective study.
Yee CL; Pal RP; Batchelder A; Khan MA
Urol Int; 2012; 88(2):165-9. PubMed ID: 22237486
[TBL] [Abstract][Full Text] [Related]
9. Thulium laser (Revolix) vapoenucleation of the prostate is a safe procedure in patients with an increased risk of hemorrhage.
Hauser S; Rogenhofer S; Ellinger J; Strunk T; Müller SC; Fechner G
Urol Int; 2012; 88(4):390-4. PubMed ID: 22627127
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.
Peng B; Wang GC; Zheng JH; Xia SQ; Geng J; Che JP; Yan Y; Huang JH; Xu YF; Yang B
BJU Int; 2013 Apr; 111(4):633-7. PubMed ID: 23107074
[TBL] [Abstract][Full Text] [Related]
11. A prospective, randomized trial comparing thulium vapoenucleation with holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic obstruction: perioperative safety and efficacy.
Netsch C; Becker B; Tiburtius C; Moritz C; Becci AV; Herrmann TRW; Gross AJ
World J Urol; 2017 Dec; 35(12):1913-1921. PubMed ID: 28698991
[TBL] [Abstract][Full Text] [Related]
12. Thulium Vaporesection of the Prostate and Thulium Vapoenucleation of the Prostate: A Retrospective Bicentric Matched-Paired Comparison with 24-Month Follow-Up.
Becker B; Buttice S; Magno C; Gross AJ; Netsch C
Urol Int; 2018; 100(1):105-111. PubMed ID: 29186715
[TBL] [Abstract][Full Text] [Related]
13. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
[TBL] [Abstract][Full Text] [Related]
14. Thulium laser vaporesection versus transurethral electrovaporization of the prostate in high-risk patients with benign prostatic hyperplasia.
Zhu Z; Shen Z; Tu F; Zhu Y; Sun F; Shao Y; Wang H; Zhong S; Xu C
Photomed Laser Surg; 2012 Dec; 30(12):714-8. PubMed ID: 23113512
[TBL] [Abstract][Full Text] [Related]
15. Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study.
Chang CH; Lin TP; Chang YH; Huang WJ; Lin AT; Chen KK
BMC Urol; 2015 May; 15():40. PubMed ID: 25956819
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 120-200 W 2 μm thulium:yttrium-aluminum-garnet vapoenucleation of the prostate.
Netsch C; Bach T; Pohlmann L; Herrmann T; Gross AJ
J Endourol; 2012 Mar; 26(3):224-9. PubMed ID: 22191688
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal changes in erectile function after thulium:YAG prostatectomy for the treatment of benign prostatic obstruction: a 1-year follow-up study.
Chung JS; Park SH; Oh CK; Kim SC; Kim TS; Kang PM; Seo WI; Kim WS; Yoon JH; Kang DI; Min KS; Chung JI
Lasers Med Sci; 2017 Sep; 32(7):1517-1523. PubMed ID: 28685201
[TBL] [Abstract][Full Text] [Related]
18. Analysis of early morbidity and functional outcome of thulium: yttrium-aluminum-garnet laser enucleation for benign prostate enlargement: patient age and prostate size determine adverse surgical outcome.
Rausch S; Heider T; Bedke J; Kruck S; Schwentner C; Fischer K; Stenzl A; Kälble T
Urology; 2015 Jan; 85(1):182-8. PubMed ID: 25530383
[TBL] [Abstract][Full Text] [Related]
19. [Effect and impact of holmium laser versus thulium laser enucleation of the prostate on erectile function].
Hong K; Liu YQ; Lu J; Xiao CL; Huang Y; Ma LL
Zhonghua Nan Ke Xue; 2015 Mar; 21(3):245-50. PubMed ID: 25898557
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic vaporesection of the prostate using the continuous-wave 2-microm thulium laser: outcome and demonstration of the surgical technique.
Szlauer R; Götschl R; Razmaria A; Paras L; Schmeller NT
Eur Urol; 2009 Feb; 55(2):368-75. PubMed ID: 19022557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
